Absolutely stunned...
I don't know who is the bigger
Absolutely stunned...
I don't know who is the bigger criminal today - JF for knowing behind the scenes everything was a joke and bailing out albeit illegally doing so or Dr. Hirsch and team for committing legal theft by doubling all the employee salaries including his own at time when no revenues are anywhere on the horizon and being dishonest about the direction of the company during the 2017 year-end report and the presentation at the investor's conference this past February.
All the signs for the blatant dishonesty were there; I was too foolish and ignored sign after sign after sign. So much for the "many positive catalysts" remark during the presentation.
No revenue on the horizon means at least an additional 10-12+ million shares of dilution over the next year just to pay the outrageous dividend. For the next round of financing, what will that cost? 50 million - 100 million shares of additional dilution. What do they care? They can just issue another round of stock options to themselves to counter the effects of the dilution while the rest of us watch our investment go down the drain.
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...
Continue Reading
Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....
Continue Reading
Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...
Continue Reading
Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...
Continue Reading
aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...
Continue Reading